CLINICAL COURSE OF OSTEOARTHRITIS IN COMBINATION WITH DIABETES MELLITUS
DOI:
https://doi.org/10.11603/1811-2471.2023.v.i1.13727Keywords:
osteoarthritis, type 2 diabetes mellitus, insulin resistance, radiological stagesAbstract
SUMMARY. The aim – to study the features of the clinical course of osteoarthritis in combination with type 2 diabetes mellitus (DM).
Material and Methods. The following clinical groups of dynamic observation were selected: Group I – 58 patients with osteoarthritis, Group II – 38 patients with osteoarthritis in combination with diabetes mellitus, Group III – 25 practically healthy people. By age and gender, the comparison groups did not differ significantly, they were comparable. In order to assess the pain syndrome and the general condition of the patient, the Lequesne algofunctional index was used. Deformation of the joints was assessed by three types of changes: limitation of range of motion; axial deformation; violation of the contact of articular surfaces. All patients underwent X-ray examination of the affected joints to determine the X-ray stage of osteoarthritis. Insulin resistance was assessed using the homeostatic model method - HOMA (homeostasis model assessment).
Results. In the group of patients with osteoarthritis in combination with diabetes mellitus, the course of osteoarthritis is severe with limitation of the amplitude of movements in the joints, their deformation and significant deterioration of functional capacity, periodic long-term exacerbations, progression and generalization of processes in various joints, especially the predominance of damage to the knee and hip joints. The authors note that such a clinical course indicates the worst prognosis. Aggravation of the course and prognosis of osteoarthritis was more often registered in women. Due to the multisystemic lesions, the progression of insulin resistance, patients must be observed, consulted and treated by a rheumatologist, traumatologist and endocrinologist.
Conclusions. The course of osteoarthritis with type 2 DM changes the clinical picture, the intensity of the joint syndrome, contributes to greater destruction of cartilage and bones, is accompanied by severe damage to the hip joints and their combination with damage to the knee joints with stage II and a higher degree of functional failure of the joints, impaired mobility and daily activities, condition insulin resistance, duration and severity of concomitant diseases.
References
Voloshin, L.O., Kovalishin, I.R., & Marchuk, Yu.F. (2013). Osteoartroz і cukrovij dіabet: epіdemіologіchnі osoblivostі, klіnіko-patogenetichnі, gendernі ta vіkovі aspekti [Osteoarthritis and diabetes mellitus: epidemiological features, clinical and pathogenetic, gender and age aspects]. Mіzhnarodnyi endokrinologіchnyi zhurnal - International Journal of Endocrinology, (6), 93-94 [in Ukrainian].
Golovach, I.Yu. (2015). Osteoartrit, іndukovanij ozhirіnniam: multifaktorіalnі asocіacіi ta provіdna rol adipokіnіv, dislіpіdemіi ta mehanіchnoho navantazhennia. [Obesity-induced Osteoarthritis: the Multifactorial Interrelation and the Leading Role of Adipokines, Dyslipidemia and Mechanical Loading]. Travma – Trauma, 16 (4), 70-78 [in Ukrainian]. DOI: https://doi.org/10.22141/1608-1706.4.16.2015.80172
Golovkina, E.U., Yutovets, T.S., Naumenko, N.V., & Ermolaeva, M.V. (2013). Osobennosti techeniia, patogeneza i lecheniia gonartroza i koksartroza u bolnyh s metabolicheskim sindromom [Features of the course, pathogenesis and treatment of gonarthrosis and coxarthrosis in patients with metabolic syndrome]. Ukrainskyi revmatologіchnyi zhurnal - Ukrainian Rheumatology Journal, (3), 114-115 [in Russian].
Dubikov, A.I. (2013). Osteoartroz: staraja bolj, novye podhody [Osteoarthrosis: old pain, new approaches]. Sovremennaia revmatologija - Modern Rheumatology, 2, 82-83 [in Russian]. DOI: https://doi.org/10.14412/1996-7012-2013-2388
Ilashchuk, T.O., Shvets, N.V., & Zakharchuk, T.V. (2014). Arterіalna hіpertenzіia, disfunkcіia nirok ta osteoartroz u pacіientіv z ozhyrіnniam [Arterial hypertension, dysfunction of kidneys and osteoarthritis in overweighted patients]. Bukovynskyi medychnyi vіsnyk - Bukovynian Medical Bulletin, 18 (2), 148-52 [in Ukrainian].
Kit, Z.M., & Strilchuk, L.M. (2015). Vpliv atorvastatinu ta ursodezoksiholevoii kisloty na vmіst leptinu krovі u hvorikh na arterіalnu hіpertenzіiu [The effect of atorvastatin and ursodeoxycholic acid on blood leptin content in patients with hypertension]. Bukovynskyi medychnyi vіsnyk – Bukovynian Medical Bulletin, 19(1), 73-75 [in Ukrainian]. DOI: https://doi.org/10.24061/2413-0737.XIX.1.73.2015.17
Serdulets, Yu.I. (2018). Osoblyvosti klinichnoho perebihu osteoartrozu, poiednanoho z tsukrovym diabetom 2-ho typu, ozhyrinniam ta arterialnoiu hipertenziieiu [Peculiarities of clinical course of osteoarthritis combined with type 2 diabetes mellitus, obesity and hypertension]. Vestnik Kluba Pankreatologov – Herald of Pancreatic Club (4), 42-46 [in Ukrainian]. DOI: https://doi.org/10.33149/vkp.2018.04.06
Courties A., Gualillo O., Berenbaum F., & Sellam J. (2015). Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage, 23(11), 1955-1965. DOI: 10.1016/j.joca .2015.05.016. DOI: https://doi.org/10.1016/j.joca.2015.05.016
de Munter, W., van der Kraan, P.M., van den Berg, W.B., & van Lent, P.L. (2016). High systemic levels of low-density lipoprotein cholesterol: fuel to the flames in inflammatory osteoarthritis? Rheumatology (Oxford), 55(1), 16-24. Doi: 10.1093/rheumatology/kev270. DOI: https://doi.org/10.1093/rheumatology/kev270
Vincent, H.K., Percival, S.S., Conrad, B.P., Seay, A.N., Montero, C., & Vincent, K.R. (2013). Hyaluronic Acid (HA) Viscosupplementation on Synovial Fluid Inflammation in Knee Osteoarthritis: A Pilot Study. The Open Orthopaedics Journal, 20(7), 378-384. DOI: 10.2174/ 1874325001307010378. DOI: https://doi.org/10.2174/1874325001307010378
Verbruggen, G., Wittoek, R., Vander Cruyssen, B., & Elewaut, D. (2012). Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Annals of the Rheumatic Diseases, 71(6), 891-898. DOI: 10.1136/ard.2011.149849. DOI: https://doi.org/10.1136/ard.2011.149849
